[HTML][HTML] Bile acids and their receptors: modulators and therapeutic targets in liver inflammation

A Bertolini, R Fiorotto, M Strazzabosco - Seminars in immunopathology, 2022 - Springer
Bile acids participate in the intestinal emulsion, digestion, and absorption of lipids and fat-
soluble vitamins. When present in high concentrations, as in cholestatic liver diseases, bile …

[HTML][HTML] The exposome and liver disease-how environmental factors affect liver health

R Barouki, M Samson, EB Blanc, M Colombo… - Journal of …, 2023 - Elsevier
Since the initial development of the exposome concept, much effort has been devoted to the
characterisation of the exposome through analytical, epidemiological, and toxicological …

[HTML][HTML] Commensal microbiota regulates skin barrier function and repair via signaling through the aryl hydrocarbon receptor

A Uberoi, C Bartow-McKenney, Q Zheng, L Flowers… - Cell host & …, 2021 - cell.com
The epidermis forms a barrier that defends the body from desiccation and entry of harmful
substances, while also sensing and integrating environmental signals. The tightly …

[HTML][HTML] Duodenum Intestine-Chip for preclinical drug assessment in a human relevant model

M Kasendra, R Luc, J Yin, DV Manatakis, G Kulkarni… - Elife, 2020 - elifesciences.org
Induction of intestinal drug metabolizing enzymes can complicate the development of new
drugs, owing to the potential to cause drug-drug interactions (DDIs) leading to changes in …

Multidrug efflux transporter ABCG2: expression and regulation

S Kukal, D Guin, C Rawat, S Bora, MK Mishra… - Cellular and Molecular …, 2021 - Springer
The adenosine triphosphate (ATP)-binding cassette efflux transporter G2 (ABCG2) was
originally discovered in a multidrug-resistant breast cancer cell line. Studies in the past have …

[HTML][HTML] Bile acid-mediated signaling in cholestatic liver diseases

J Zeng, J Fan, H Zhou - Cell & Bioscience, 2023 - Springer
Chronic cholestatic liver diseases, such as primary biliary cholangitis (PBC) and primary
sclerosing cholangitis (PSC), are associated with bile stasis and gradually progress to …

Rhamnetin decelerates the elimination and enhances the antitumor effect of the molecular-targeting agent sorafenib in hepatocellular carcinoma cells via the miR …

B Li, F Feng, H Jia, Q Jiang, S Cao, L Wei, Y Zhang… - Food & Function, 2021 - pubs.rsc.org
The pregnane X receptor (PXR) mediates the resistance of sorafenib in hepatocellular
carcinoma (HCC) by promoting the clearance or elimination of sorafenib via the drug …

[HTML][HTML] State of knowledge on current exposure, fate and potential health effects of contaminants in polar bears from the circumpolar Arctic

H Routti, TC Atwood, T Bechshoft, A Boltunov… - Science of the Total …, 2019 - Elsevier
The polar bear (Ursus maritimus) is among the Arctic species exposed to the highest
concentrations of long-range transported bioaccumulative contaminants, such as …

[HTML][HTML] Regulation of CAR and PXR Expression in Health and Disease

M Daujat-Chavanieu, S Gerbal-Chaloin - Cells, 2020 - mdpi.com
Pregnane X receptor (PXR, NR1I2) and constitutive androstane receptor (CAR, NR1I3) are
members of the nuclear receptor superfamily that mainly act as ligand-activated transcription …

[HTML][HTML] PXR: a center of transcriptional regulation in cancer

Y Xing, J Yan, Y Niu - Acta Pharmaceutica Sinica B, 2020 - Elsevier
Abstract Pregnane X receptor (PXR, NR1I2) is a prototypical member of the nuclear receptor
superfamily. PXR can be activated by both endobiotics and xenobiotics. As a key xenobiotic …